In addition, the recruitment of cDC1 within tumors has other benefits, including the production of chemokines CXCL9 and CXCL10 to recruit CXCR3 effector T cells for tumor infiltration, and a further enhancement of the antitumor activity of T cells and NKs by cytokine IL-12 [12,48]. This evidence concerns the gene CXCR3 and neoplasm.